We are live on ! Find out more
SGC

Slocum, Gordon & Co Portfolio holdings

AUM $151M
1-Year Est. Return 26.83%
This Fund
S&P 500
This Quarter Est. Return
-3.75%
1 Year Est. Return
+26.83%
3 Year Est. Return
+55.15%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$115M
AUM Growth
-$23M
Cap. Flow
-$454K
Cap. Flow %
-0.4%
Top 10 Hldgs %
57.53%
Holding
148
New
24
Increased
8
Reduced
25
Closed
2

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$1.81M
2
KVUE icon
Kenvue
KVUE
+$1.27M
3
XOM icon
ExxonMobil
XOM
+$1.11M
4
CAG icon
Conagra Brands
CAG
+$804K
5
TMO icon
Thermo Fisher Scientific
TMO
+$354K

Top Sells

Rank Stock Value
1
VST icon
Vistra
VST
+$3.1M
2
JNJ icon
Johnson & Johnson
JNJ
+$1.2M
3
ABT icon
Abbott
ABT
+$512K
4
JPM icon
JPMorgan Chase
JPM
+$165K
5
PFE icon
Pfizer
PFE
+$163K

Sector Composition

Rank Sector Weight
1 Healthcare 29.48%
2 Utilities 20.38%
3 Consumer Staples 15.96%
4 Energy 12.24%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
Merck
MRK
$321B
$10.9M 9.5%
105,988
-871
-0.8% -$93.9K
PG icon
2
Procter & Gamble
PG
$335B
$8.42M 7.33%
57,741
-630
-1% -$96.2K
XOM icon
3
ExxonMobil
XOM
$651B
$8.26M 7.2%
70,283
+10,122
+17% +$1.11M
JNJ icon
4
Johnson & Johnson
JNJ
$617B
$8.15M 7.1%
52,335
-7,249
-12% -$1.2M
ABBV icon
5
AbbVie
ABBV
$455B
$6.3M 5.49%
42,294
-850
-2% -$125K
AEP icon
6
American Electric Power
AEP
$69.5B
$5.7M 4.96%
75,742
-1,045
-1% -$85K
PFE icon
7
Pfizer
PFE
$142B
$5.41M 4.71%
163,059
-4,600
-3% -$163K
VST icon
8
Vistra
VST
$50.1B
$4.48M 3.9%
135,000
-103,154
-43% -$3.1M
NEE icon
9
NextEra Energy
NEE
$183B
$4.45M 3.87%
77,597
-1,100
-1% -$76.2K
PPL
10
PPL Corp
PPL
$26.8B
$3.98M 3.47%
168,915
-5,232
-3% -$135K
VZ icon
11
Verizon
VZ
$193B
$3.32M 2.89%
102,395
+44
+0% +$1.49K
DUK icon
12
Duke Energy
DUK
$98.4B
$2.89M 2.52%
32,739
– –
WY icon
13
Weyerhaeuser
WY
$16.9B
$2.71M 2.36%
88,300
– –
KMB icon
14
Kimberly-Clark
KMB
$36.6B
$2.59M 2.26%
21,470
-645
-3% -$83.3K
OXY icon
15
Occidental Petroleum
OXY
$55.6B
$2.54M 2.21%
39,082
-835
-2% -$52.5K
JPM icon
16
JPMorgan Chase
JPM
$933B
$2.41M 2.1%
16,650
-1,100
-6% -$165K
WMB icon
17
Williams Companies
WMB
$86.7B
$2.29M 1.99%
68,002
-1,475
-2% -$50.3K
CL icon
18
Colgate-Palmolive
CL
$73.3B
$2.04M 1.78%
28,681
+24,235
+545% +$1.81M
AAPL icon
19
Apple
AAPL
$4.9T
$1.75M 1.53%
10,236
+300
+3% +$55K
D icon
20
Dominion Energy
D
$61.3B
$1.69M 1.48%
37,921
-1,110
-3% -$55.1K
T icon
21
AT&T
T
$159B
$1.69M 1.47%
112,250
-7,762
-6% -$114K
UL icon
22
Unilever
UL
$141B
$1.45M 1.26%
26,059
– –
MMM icon
23
3M
MMM
$90.8B
$1.38M 1.21%
17,686
-60
-0.3% -$5.15K
MSFT icon
24
Microsoft
MSFT
$3.35T
$1.24M 1.08%
3,914
– –
IBM icon
25
IBM
IBM
$209B
$1.23M 1.07%
8,738
– –
1
2 3 4 5

Similar funds

LM
Lansing Management New York $151M AUM 13.85% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
FC
FACT Capital New York $150M AUM 53.4% 1-Year Est. Return
JIM
JCP Investment Management Houston, Texas $150M AUM 19.22% 1-Year Est. Return
WBCM
Wilson & Boucher Capital Management Moraga, California $151M AUM 18.75% 1-Year Est. Return
BDS
Banco de Sabadell Miami, Florida $151M AUM 22.94% 1-Year Est. Return
CCM
Crew Capital Management Cincinnati, Ohio $151M AUM 20.49% 1-Year Est. Return
SHF
Stage Harbor Financial Westwood, Massachusetts $151M AUM 15.9% 1-Year Est. Return

Slocum, Gordon & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Slocum, Gordon & Co held 148 positions worth $115M, down 17% from $138M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Slocum, Gordon & Co's Q3 2023 filing shows 24 new, 8 increased, 25 reduced and 2 closed positions. Its largest new stake was Kenvue: 54,750 shares worth $1.1M. The largest sale was Vistra, an estimated $3.1M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Utilities and Consumer Staples.

  • Slocum, Gordon & Co's largest Q3 2023 buy was Kenvue: 54,750 shares worth $1.1M.
  • Slocum, Gordon & Co added most to Colgate-Palmolive in Q3 2023, an estimated $1.81M increase.
  • Slocum, Gordon & Co's biggest Q3 2023 reduction was Vistra, cutting an estimated $3.1M.
  • Slocum, Gordon & Co fully exited Abbott in Q3 2023, selling an estimated $512K.
  • Slocum, Gordon & Co's ten largest holdings make up 58% of its $115M portfolio in Q3 2023.
  • Slocum, Gordon & Co opened 24 new positions and closed 2 in Q3 2023.
  • Slocum, Gordon & Co's portfolio value fell 17% quarter-over-quarter to $115M.

Based on Slocum, Gordon & Co's 13F filing for Q3 2023, filed 9 Nov 2023.